Skip to content
10-Q

Quarterly Report

Aerie Pharmaceuticals, Inc.

0001337553-22-000033

← back to feed
Filed
Aug 5, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 29, 2022 49.36M sh
Shares Diluted Q2 2022 · Jun 30, 2022 47.56M sh
Shares Diluted Q2 2022 · Jun 30, 2022 47.54M sh
Shares Diluted Q2 2022 · Jun 30, 2021 46.2M sh
Shares Diluted Q2 2022 · Jun 30, 2021 46.15M sh
Capex Q2 2022 · Jun 30, 2022 $2.97M
Capex Q2 2022 · Jun 30, 2021 $1.38M
Operating Cash Flow Q2 2022 · Jun 30, 2022 $48.68M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$50.19M
Short Term Investments Q2 2022 · Jun 30, 2022 $144.93M
Short Term Investments Q2 2022 · Dec 31, 2021 $102.61M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $39.44M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $37.19M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$141.13M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$125.71M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$17.33M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$39.61M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$10.37M
Stockholders Equity Q2 2022 · Dec 31, 2020 $23.97M
Current Liabilities Q2 2022 · Jun 30, 2022 $119.66M
Current Liabilities Q2 2022 · Dec 31, 2021 $124.99M
Total Liabilities Q2 2022 · Jun 30, 2022 $526.47M
Total Liabilities Q2 2022 · Dec 31, 2021 $448.72M
Current Assets Q2 2022 · Jun 30, 2022 $311.41M
Current Assets Q2 2022 · Dec 31, 2021 $355.65M
Total Assets Q2 2022 · Jun 30, 2022 $385.34M
Total Assets Q2 2022 · Dec 31, 2021 $431.39M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.41
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.16
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.84
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.75
Eps Basic Q2 2022 · Jun 30, 2022 −$0.41
Eps Basic Q2 2022 · Jun 30, 2022 −$1.16
Eps Basic Q2 2022 · Jun 30, 2021 −$0.84
Eps Basic Q2 2022 · Jun 30, 2021 −$1.75
Sga Expense Q2 2022 · Jun 30, 2022 $28.15M
Sga Expense Q2 2022 · Jun 30, 2022 $59.67M
Sga Expense Q2 2022 · Jun 30, 2021 $34.54M
Sga Expense Q2 2022 · Jun 30, 2021 $67.14M
Rd Expense Q2 2022 · Jun 30, 2022 $19.56M
Rd Expense Q2 2022 · Jun 30, 2022 $44.73M
Rd Expense Q2 2022 · Jun 30, 2021 $17.97M
Rd Expense Q2 2022 · Jun 30, 2021 $35.86M
Net Income Q2 2022 · Jun 30, 2022 −$19.37M
Net Income Q2 2022 · Jun 30, 2022 −$55.26M
Net Income Q2 2022 · Mar 31, 2022 −$35.89M
Net Income Q2 2022 · Jun 30, 2021 −$38.69M
Net Income Q2 2022 · Jun 30, 2021 −$80.65M
Net Income Q2 2022 · Mar 31, 2021 −$41.96M
Operating Income Q2 2022 · Jun 30, 2022 −$18.14M
Operating Income Q2 2022 · Jun 30, 2022 −$51.78M
Operating Income Q2 2022 · Jun 30, 2021 −$31.5M
Operating Income Q2 2022 · Jun 30, 2021 −$65.72M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $3.74M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $10.52M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $6.18M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $12.88M
Revenue Q2 2022 · Jun 30, 2022 $33.31M
Revenue Q2 2022 · Jun 30, 2022 $63.15M
Revenue Q2 2022 · Jun 30, 2021 $27.19M
Revenue Q2 2022 · Jun 30, 2021 $50.16M